Of note, several studies have shown that PAI-1 deficiency [78,79,80], pharmacological inhibition of PAI-1 [81], and a reduction in plasma PAI-1 levels through dietary restrictions [82] are protective against the development of obesity and metabolic disorders. This evidence concerns the gene SERPINE1 and metabolic disease.